May 2 – May 5, 2013
Hyatt Fisherman’s Wharf
San Francisco, CA

COURSE FACULTY, TOPICS AND DAILY SCHEDULE
16.25 hours of CME/SAM Credit


THURSDAY - May 2nd
2:15 – 6:40 PM Registration
3:00 - 3:10 PM Welcome and Faculty introduction Jesse K. McKenney, MD (Presidio Ballroom)
3:10 - 6:40 PM Germ Cell Tumors, Sex Cord-Stromal Tumors and Other Non-Epithelial Tumors of the Ovary - Joseph T. Rabban, MD, Charles Zaloudek, MD and Karuna Garg, MD (Presidio Ballroom)
Upon completion of this presentation, participants should be able to:
  •   Recognize major sub-types of ovarian germ cell tumors, sex cord-stromal tumors and their mimics.
  •   Identify pitfalls in frozen section evaluation.
  •   Appropriately apply and interpret current immunohistochemical markers to confirm diagnosis of these tumors.
  •   State what prognostic information should be reported in the diagnosis of these tumors. 
(4:45-5:00 PM) BREAK
FRIDAY - May 3rd
7:00 - 7:50 AM Continental Breakfast for Registrants (Java/North)
7:50 - 8:00 AM Welcome and Faculty introductions Jesse K. McKenney, MD (Presidio Ballroom)
8:00 - 11:30 AM A Practical Approach to Common Problems in Gastrointestinal Pathology - John R. Goldblum, MD (Presidio Ballroom)
Upon completion of this presentation, participants should be able to:
  •   Review Barrett’s Esophagus and Barrett’s-Related Dysplasia.
  •   Describe Inflammatory Bowel Disease and IBD-Related Dysplasia.
  •   Discuss Patterns of Injury in Colorectal Biopsy Specimens.
(10:00-10:15 AM) BREAK
11:30 AM - 1:00 PMLUNCH Provided By USCAP
1:00 - 4:30 PM New Concepts in the Diagnoses and Classification of Extanodal Lymphomas - Yaso Natkunam, MD, PhD; Eric D. Hsi, MD and Daniel A. Arber, MD (Presidio Ballroom)
Upon completion of this presentation, participants should be able to:
  •   Recognize the salient features of extranodal lymphomas occurring at various anatomic locations.
  •   Describe an integrated approach to the diagnosis of extranodal lymphomas that incorporates morphologic approaches with appropriate ancillary studies.
  •   Explain the changes in the revised WHO classification of lymphoid neoplasms and the impact of immunohistologic and molecular markers on diagnosis and classification.
(2:45-3:00 PM) BREAK
5:00-6:30 PM Reception for Registrants and Accompanying Persons
SATURDAY - May 4th
7:00 - 7:50 AM Continental Breakfast for Registrants (Java/North)
7:50 – 8:00 AM Welcome and Faculty introductions Jesse K. McKenney, MD (Presidio Ballroom)
8:00 - 11:30 AM Diagnoses and Dilemmas in Pancreaticobiliary Pathology:  Neoplasms, Mimics, and Staging in Lesions of the Pancreas, Ampulla of Vater, and Gallbladder - Susan C. Abraham, MD and Alyssa M. Krasinskas, MD (Presidio Ballroom)
Upon completion of this presentation, participants should be able to:
  •   Distinguish reactive atypia from dysplasia in the gallbladder.
  •   Recognize benign lesions of the gallbladder (dysplasia confined to Rokitansky-Aschoff sinuses, adenomyoma, florid hyperplasia of Luschka’s ducts) and separate them from invasive carcinoma.
  •   Distinguish inflammatory atypia of the ampulla from adenoma/dysplasia, and separate adenomatous epithelium involving deep ampullary glands from well-differentiated adenocarcinoma.
  •   Explain autoimmune pancreatitis and its diagnosis on biopsies, and other reactive/inflammatory mimics of pancreatic carcinoma.
  •   Effectively apply the current staging systems for carcinomas of the gallbladder, ampulla, and pancreas.
(9:45-10:00 AM) BREAK
Afternoon Free
SUNDAY - May 5th
7:00 - 7:50 AM Continental Breakfast for Registrants (Java/North)
7:50 – 8:00 AM Welcome and Faculty introductions Jesse K. McKenney, MD (Presidio Ballroom)
8:00 - 11:30 AM Practical Issues in the Diagnosis, Staging, and Reporting of Prostatic Adenocarcinoma - Jesse K. McKenney, MD (Presidio Ballroom)
Upon completion of this presentation, participants should be able to
  •   Confidently approach the differential diagnosis of atypical glandular lesions in prostate needle core biopsies.
  •   Establish an approach to using adjunctive immunohistochemistry for the diagnosis of prostatic adenocarcinoma.
  •   Recognize the full spectrum of Gleason patterns and develop an approach to difficult threshold cases.
  •   Confidently stage prostatic adenocarcinoma in radical prostatectomy specimens.
(9:45-10:00 AM) BREAK
11:30 - 11:45 AM Wrap up